Produkty 4089-36-5

CAS 4089-36-5 występuje w naszej ofercie pod nazwami: Dexamethasone Oxetanone, Dexamethasone Oxetanone, >95% (HPLC). Oferty producentów: Chemat Brand, TRC, Mikromol, Biosynth, Chemat. Dostępne opakowania: on request, 100mg, 10mg, 50mg, 25mg, 10 mg, 50 mg, 100 mg.

Dexamethasone Oxetanone
Chemat Brand, Mikromol, Biosynth
  • opakowanie: on request, 25mg, 10mg, 10 mg
  • Warianty: 7
od 1777,91
Zobacz produkt
Dexamethasone Oxetanone, >95% (HPLC)
TRC
  • opakowanie: 100mg, 10mg, 50mg
  • Warianty: 3
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11-hydroxy-10,13,16-trimethylspiro[6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17,2'-oxetane]-3,3'-dione (CAS 4089-36-5) to związek chemiczny o wzorze sumarycznym C22H27FO4 i masie molowej 374.4 g/mol. Nazwa systematyczna IUPAC: (8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11-hydroxy-10,13,16-trimethylspiro[6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17,2'-oxetane]-3,3'-dione. InChIKey: PLIOZIVVVLFDAA-CXSFZGCWSA-N.

Dane identyfikacyjne
Wzór sumarycznyC22H27FO4
Masa molowa374.4 g/mol
Nazwa IUPAC(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11-hydroxy-10,13,16-trimethylspiro[6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17,2'-oxetane]-3,3'-dione
InChIKeyPLIOZIVVVLFDAA-CXSFZGCWSA-N
SMILESC[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@@]15C(=O)CO5)C)O)F)C

Dane obliczone przez PubChem (NCBI)

Synonimy: Dexamethasone oxetanone, Dexamethasone Impurity 122, orb1688510, Pregna-1,4-diene-3,20-dione, 17,21-epoxy-9-fluoro-11beta-hydroxy-16alpha-methyl-
Izomery (ten sam wzór sumaryczny)
(2Z)-2-(9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-ylidene)-2-hydroxyacetaldehyde C22H27FO4
(2E)-2-[(8S,9R,10S,11S,13S,14S,16S)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-ylidene]acetic acid C22H27FO4
(2E)-2-[(8S,10S,11S,13S,14S,16S)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-ylidene]-2-hydroxyacetaldehyde C22H27FO4
(2Z)-2-[(8S,9R,10S,11S,13S,14S,16R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-ylidene]-2-hydroxyacetaldehyde C22H27FO4
2-[(8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-7,8,11,12,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoacetaldehyde C22H27FO4
(2Z)-2-[(9R,10S,11S,13S,16S)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-ylidene]-2-hydroxyacetaldehyde C22H27FO4
(1S,2S,8S,11S,13R,14S,15S,17S)-8-fluoro-14-(2-hydroxyacetyl)-2,13,15-trimethyl-18-oxapentacyclo[8.8.0.01,17.02,7.011,15]octadeca-3,6-dien-5-one C22H27FO4
(8S,9R,10S,11S,13S,14S)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,11,12,14,15-hexahydro-6H-cyclopenta[a]phenanthren-3-one C22H27FO4
(2Z)-2-[(8S,9R,10S,11S,13S,14S,16S)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-ylidene]-2-hydroxyacetaldehyde C22H27FO4
(8S,9R,10S,13S,14S,16S,17R)-9-fluoro-17-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,14,15,16-hexahydrocyclopenta[a]phenanthren-3-one C22H27FO4
2-[(6S,8S,9S,10R,11S,13S,14S,16R,17S)-6-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoacetaldehyde C22H27FO4